Rapid Adoption Position MicrobeDx as a rapid decision-support solution for hospitals and EDs through its phenotypic AST, enabling antibiotic stewardship programs to shorten time to effective therapy. Propose pilot deployments in clinical microbiology labs to demonstrate reductions in inappropriate antibiotic use and faster patient triage.

Broad Coverage Highlight universal applicability across bacterial pathogens with a phenotypic AST that does not require updating gene target panels, appealing to mid-to-large labs seeking scalable, low-maintenance testing. Target reference labs and regional hospital systems that need broad-spectrum diagnostic coverage.

Channel Partnerships With a lean team, pursue partnerships with diagnostic distributors, CROs, and healthcare IT vendors to accelerate market reach. Consider channel sales and white-labeling arrangements to integrate MicrobeDx testing into existing lab workflows and hospital supply chains.

Platform Enablement Offer enterprise-grade IT integration, including LIMS/EHR compatibility, secure data exchange, and analytics dashboards to help labs monitor performance and outcomes. This can be a differentiator against consumer-grade website and app tooling and supports large-scale deployment.

Market Expansion Target geographic expansion from California to national networks by focusing on community hospitals, urgent care centers, and outpatient clinics with antibiotic stewardship objectives. Emphasize the cost savings, improved patient outcomes, and reduced antibiotic resistance through rapid, actionable testing.